SCHEMBL6580688

SCHEMBL6580688

Cc1ccc2cc(OCc3c(CS)ccc([N+](=O)[O-])c3CS)ccc2n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.36
MAPT P10636 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
CYP1A2 P05177 2/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HIF1A Q16665 1/20 0.35
GAA P10253 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAOB P27338 3/20 0.35
LMNA P02545 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
S1PR4 O95977 2/20 0.34
INPPL1 O15357 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6581453 0.81 ALDH1A1 (0.40) ALDH1A1MAPTSMN1; SMN2CYP1A2TP53
SCHEMBL6581385 0.79 TP53 (0.42) ALDH1A1MAPTSMN1; SMN2CYP1A2TP53
SCHEMBL7913293 0.78 MEN1 (0.56) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL6578371 0.77 ALDH1A1 (0.44) ALDH1A1MAPTSMN1; SMN2CYP1A2CYP2D6
SCHEMBL6580686 0.76 S1PR4 (0.44) ALDH1A1MAPTSMN1; SMN2CYP1A2TP53
SCHEMBL6576127 0.76 S1PR4 (0.42) ALDH1A1MAPTSMN1; SMN2CYP1A2TP53
SCHEMBL6578500 0.76 ALDH1A1 (0.43) ALDH1A1MAPTSMN1; SMN2CYP1A2CYP2D6
SCHEMBL6576231 0.75 MAPT (0.40) ALDH1A1MAPTSMN1; SMN2CYP1A2TP53
SCHEMBL6581287 0.74 MAPT (0.42) ALDH1A1MAPTSMN1; SMN2CYP1A2CYP2D6
SCHEMBL6580761 0.73 MAPT (0.42) ALDH1A1MAPTSMN1; SMN2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0867432-B1 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists AVENTIS PHARMA GMBH (DE) 2004-06-09 EP disclosed
EP-0867432-A2 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-30 EP disclosed